Yesterday at our research conference, one popular session focused on bone health for cancer survivors. More than 40 million adults in the US have or are at high risk for osteoporosis, a bone weakening disease.
Often due to some cancer therapies, survivors are at higher risk for bone loss and osteoporosis than the general population.
Breast and prostate cancer treatments may cause low estrogen or androgen levels, two hormones important for strong bones.
Between sessions, I talked with several oncology dietitians about how they work with survivors on bone health in their centers and clinics. While not unanimous, most RDs said their patients are very aware of their increased risk for bone loss and receive DEXA screening — a test for bone mineral density — and treatment, including diet and lifestyle prescriptions as well as appropriate medications. Continue reading